Neuroquiescence—a treatment for neurodevelopmental and neurodegenerative bioelectrical dysregulation and demyelination
US11446262B2 · kind B2 · utility
0Cited by
10References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 21, 2020 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Nov 18, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0053
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present inventive concept defines as “Neuroquiescence” a method for treating neurovascular dysregulation underlying neurodevelopmental and neurodegenerative dysfunctions by improving immunovascular robustness for fueling glial cells while pausing neuronal bioelectrical activity for remyelination and astrocyte resetting cellular homeostasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.